Skip to content

Hobbs Medical TouchSoft Coagulator G1120040Recalls & reported problems

Hobbs Medical, Inc. · An assembly of devices that uses radio-frequency (RF) alternating current to develop heat directly within soft-tissue cells (thermodynamic) for cutting and coagulating tissue within a shield of argon (Ar) gas during surgery. It typically includes a generator, a single-use/reusable electrode handpiece with monopolar electrodes, connecting cables, foot-switch, and an argon gas supply system [housed in a separate trolley (cart) or incorporated into the system generator]. The current forms an ionized channel or arc within the argon shield which lessens the charring of tissue and provides rapid, uniform coagulation over large bleeding surfaces (e.g., capillary beds). · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI M849G11200400), received between Mar 4, 2025 and Mar 4, 2025 — classified as 1 death.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Bowel Perforation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • DeathMar 4, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT HOSPITAL "HAD A PATIENT THAT HAD 2 DUODENAL AVMS, FOR WHICH THE TOUCHSOFT PROBE WAS USED. THE SETTINGS WERE APPROPRIATE, WITH IT BEING ON SOFT COAG. AND AT 30-40 WATTS. THE COAGULATION APPEARED TO BE APPROPRIATE. THE PATIENT WAS DISCHARGED, AND A DAY LATER WAS HAVING ABDOMINAL PAIN. THE PATIENT HAD A DUODENAL PERFORATION REQUIRING SURGERY." UPON FOLLOW-UP, THE HOSPITAL EXPLAINED, TWO DAYS AFTER THE SURGERY, THE PATIENT CALLED THE DOCTOR COMPLAINING ABOUT PAIN. THE PATIENT RETURNED TO THE HOSPITAL, AND THE DOCTOR FOUND AN INFECTION IN THE DUODENUM. THE PATIENT WAS ADMITTED TO THE HOSPITAL WHERE A CT SCAN WAS PERFORMED, AND A PERFORATION WAS FOUND. THE PATIENT WAS TAKEN TO SURGERY AND THEN WAS ADMITTED TO THE ICU, WHERE THE PATIENT REMAINED FOR SIX WEEKS UNTIL PASSING AWAY. IN ADDITION, THE HOSPITAL REPRESENTATIVE STATED THAT THE PATIENT HAD SEVERAL OTHER CO-MORBIDITIES AND DID NOT KNOW EXACTLY WHAT CAUSED THIS EVENT TO HAPPEN. THE HOSPITAL REPRESENTATIVE STATED THAT THE DOCTOR DID NOT THINK THAT THE PROBE CONTRIBUTED TO THE PATIENT'S PASSING BUT CANNOT RULE IT OUT. AVMS WERE 2 SMALL, NONBLEEDING ANGIODYSPLASIAS LOCATED IN THE SECOND PORTION OF THE DUODENUM. TOUC

    Patient problems: Bowel Perforation

    MAUDE report 21517346 ↗

Other Unit, Electrosurgical, Endoscopic (With Or Without Accessories) devices

All Unit, Electrosurgical, Endoscopic (With Or Without Accessories) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page